Abstract
e15139 Background: No effective treatments for patients with advanced HCC who are intolerant to sorafenib or who have progressed during sorafenib are available. Several studies suggest a relationsh...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
